EFSA reaffirms safety of MON 863 maize
The European Food Safety Authority’s (EFSA) Scientific Panel on Genetically Modified Organisms (GMO Panel) has published today a statement reaffirming the conclusions of its risk assessment adopted on 2 April 2004 confirming the safety of MON 863 maize*.
On 20 September 2004 the Regulatory Committee under Directive 2001/18/EC discussed a draft Commission decision on the authorization for the placing on the market of genetically modified maize MON 863. Following discussions concerning another evaluation, submitted by German authorities, of one of the studies reviewed by the EFSA Panel, the European Commission decided to postpone the vote on MON 863 maize. The Commission has sought scientific advice from EFSA as to whether this new evaluation might have any impact on the former opinions issued by the GMO Panel related to MON 863 maize.
Following further investigation and careful consideration of the recently published information** made available to EFSA, the GMO Panel concluded that the evidence presented does not affect its previous scientific advice with regards to MON 863. In its opinion, the GMO Panel concluded that “the placing on the market of MON 863 maize is unlikely to have an adverse effect on human and animal health or on the environment, in the context of its intended use.”
**Evaluation of and Final Report on the summary report of the "13-Week Dietary Subchronic Comparison Study with MON 863 in Rats Preceded by a 1-Week Baseline Food Consumption Determination with PMI Certified Diet #5002 (Report MSL-18175/Covance Study No. 6103-293)", dated 15 September 2004.
How to contact us
EFSA Media Relations Office
Tel. +39 0521 036 149
E-mail: press [at] efsa.europa.eu (Press[at]efsa[dot]europa[dot]eu)
(Only if you are a member of the press)
Ask a Question Service
You have a question about EFSA’s work? Contact our Ask a Question service!